Novavax COVID-19 vaccine trial results show efficacy against the B.1.351 variant in SA study

Piecing together the preterm infant microbiome
6 May 2021
Study of airborne transmission of COVID-19 will help reopen large recreational events
6 May 2021

Novavax COVID-19 vaccine trial results show efficacy against the B.1.351 variant in SA study

The New England Journal of Medicine (NEJM) today published findings of the Phase 2b clinical trial conducted in South Africa.

Comments are closed.